
Talaris Therapeutics
Talaris Therapeutics is a therapeutic based company.
Market cap
$127m
Enterprise value
($25m)
Share price
$2.72 TALS
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
* | N/A | Acquisition | |
Total Funding | 000k |

Citadel(exited)

Viking Global Investors(exited)

Cormorant Asset Management(exited)

Invus(exited)

BlackRock(exited)

Eventide Asset Management(exited)

Logos Capital(exited)

Aisling Capital(exited)

Pamoja Capital Group(exited)

Blackstone(exited)

Longitude Capital(exited)

Qiming Venture Partners USA(exited)
USD | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
EBITDA | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.